Facilitators of adherence to the study pill in the FEM-PrEP clinical trial. by Amy Corneli, Brian Perry, Kawango Agot, Khatija Ahmed, Fulufhelo Malamatsho, Lut Van Damme

Get full text

Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: lessons learned from a microbicide phase III clinical trial. by Tania Crucitti, Katrien Fransen, Rashika Maharaj, Tom Tenywa, Marguerite Massinga Loembé, Kailapuri Gangatharan Murugavel, Kevin Mendonca, Said Abdellati, Greet Beelaert, Lut Van Damme

Get full text

Verification of chemistry reference ranges using a simple method in sub-Saharan Africa by Irith De Baetselier, Douglas Taylor, Justin Mandala, Kavita Nanda, Christel Van Campenhout, Walter Agingu, Lorna Madurai, Eva-Maria Barsch, Jennifer Deese, Lut Van Damme, Tania Crucitti

Get full text

The sexual risk context among the FEM-PrEP study population in Bondo, Kenya and Pretoria, South Africa. by Jennifer Headley, Ansley Lemons, Amy Corneli, Kawango Agot, Khatija Ahmed, Meng Wang, Jacob Odhiambo, Joseph Skhosana, Jenae Tharaldson, Lut Van Damme, Kathleen MacQueen, FEM-PrEP Study Group

Get full text

Evaluation of a behavior-centered design strategy for creating demand for oral PrEP among young women in Cape Town, South Africa [version 2; peer review: 2 approved] by Jennifer F. Morton, Laura Myers, Katherine Gill, Linda-Gail Bekker, Gabrielle Stein, Katherine K. Thomas, Menna Duyver, Ariane van der Straten, Margaret McConnell, Robert Aunger, Valerie Curtis, Jessie de Witt Huberts, Lut Van Damme, Jared M. Baeten, Connie Celum

Get full text